Quick Takeaways
- Michael J. Detke has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $131,600.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Michael J. Detke
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Michael J. Detke is at least $131,600 dollars as of 04 Mar 2022. Michael J. Detke is the Chief Medical Officer of Cortexyme, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $131.6K.
- Signature
- /s/ Caryn Gordon McDowell, Attorney-in-Fact for Michael J. Detke, M.D.
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Michael J. Detke and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Cortexyme, Inc. ($131,600).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Michael J. Detke
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QNCX | Cortexyme, Inc. | Chief Medical Officer | $131,600 | 03 Mar 2022 |
Insider Transactions Reported by Michael J. Detke:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.